Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan

Akemi Tomoda, Keiko Nomura, Seiji Shiraishi, Akinobu Hamada, Takafumi Ohmura, Mitsuaki Hosoya, Teruhisa Miike, Yukio Sawaishi, Hiroshi Kimura, Hiroshi Takashima, Yoshihiro Tohda, Kenji Mori, Zenichiro Kato, Ai Fukushima, Hisanori Nishio, Akio Nezu, Kenji Nihei

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Ten patients with SSPE were surveyed during the last 4 years from the viewpoint of clinical safety for use of ribavirin therapy. Although effectiveness varied among cases, they were all treated safely with intraventricular ribavirin. This study suggests that treatment is safe and well-tolerated.

Original languageEnglish
Pages (from-to)514-517
Number of pages4
JournalBrain and Development
Volume25
Issue number7
DOIs
Publication statusPublished - Oct 2003

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan'. Together they form a unique fingerprint.

  • Cite this

    Tomoda, A., Nomura, K., Shiraishi, S., Hamada, A., Ohmura, T., Hosoya, M., Miike, T., Sawaishi, Y., Kimura, H., Takashima, H., Tohda, Y., Mori, K., Kato, Z., Fukushima, A., Nishio, H., Nezu, A., & Nihei, K. (2003). Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan. Brain and Development, 25(7), 514-517. https://doi.org/10.1016/S0387-7604(03)00062-7